You are here:  Home  >  Biotech  >  Current Article

Sientra shares soar as earnings beat expectations

By   /   Thursday, November 7th, 2019  /   Comments Off on Sientra shares soar as earnings beat expectations

    Print       Email
Goleta breast implant developer Sientra announced plans to streamline its miraDry operations and acquire its Opus brand manufacturer from Lubrizol Life Science for $20 million in cash. In an accompanying earnings statement, the company also hiked up its guidance for the year after a quarter in which sales rose 33 percent and net losses beat…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

Dubroff: U.S. Bank’s big buy revives long-simmering rivalry with Wells Fargo

Read More →